<DOC>
	<DOC>NCT00337675</DOC>
	<brief_summary>This is a year-long study evaluating the efficacy of both daily and intermittent treatment of asthma in children who experience symptoms episodically (i.e., seasonally, usually in the context of upper respiratory tract infection).</brief_summary>
	<brief_title>Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patients aged 6 months to 5 years with episodic (periodic) asthma Patients who are not in otherwise good health Patients who have persistent asthma (continual asthma symptoms)</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>